Advertisement

Familial Breast Cancer: Detection of Prevalent High-Risk Epithelial Lesions

  • Peter Bult
  • Nicoline Hoogerbrugge
Part of the Methods of Cancer Diagnosis, Therapy and Prognosis book series (HAYAT, volume 1)

BRCA1 and BRCA2 mutation carriership is associated with a highly increased risk of developing breast carcinoma. For women carrying a BRCA mutation, the risk of breast cancer begins to increase before the age of 25, with a steep increase after the age of 40 years. The cumulative risk of developing breast cancer before the age of 40 years is ∼ 15%, while the cumulative risk of developing breast cancer before the age of 50 is 40–50% (Ford et al., 1998). The life time risk of invasive breast cancer is 60–80%. Very little is known regarding the early stages of breast cancer development in the inherited forms of the disease. Women with hereditary predisposition to breast cancer are prone to develop epithelial lesions that indicate a high risk of subsequent invasive breast cancer (Dupont and Page, 1985; Hoogerbrugge et al., 2003). These high-risk lesions include atypical lobular hyperplasia (ALH), atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCIS), and ductal carcinoma in situ (DCIS) (Kauff et al., 2003). These epithelial lesions may predict the occurrence of subsequent invasive breast cancer (Singletary, 1994).

Keywords

Breast Cancer Contralateral Prophylactic Mastectomy Atypical Ductal Hyperplasia Prophylactic Mastectomy Familial Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bramley, M., Clarke, R.B., Howell, A., Evans, D.G.R., Armer, T., Baildam, A.D., and Anderson, E. 2006. Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations. Br. J. Cancer 94: 1021–1028PubMedCrossRefGoogle Scholar
  2. Claus, E.B., Petruzella, S., Matloff, E., and Carter, D. 2005. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal car cinoma in situ. J. A. M. A. 293: 964–969PubMedCrossRefGoogle Scholar
  3. Dupont, W.D., and Page, D.L. 1985. Risk factors for breast cancer in women with proliferative breast disease. New. Eng. J. Med. 312: 146–151PubMedGoogle Scholar
  4. Easton, D.F., Deffenbaugh, A.M., Pruss, D., Frye, C., Wenstrup, R.J., Allen-Brady, K., Tavtigian, S.V., Monteiro, A.N., Iversen, E.S., Couch, F.J., and Goldgar, D.E. 2007. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am. J. Hum. Genet. 81: 873–883PubMedCrossRefGoogle Scholar
  5. Egan, R.L. 1982. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ stud ies and 10-year survival. Cancer 49: 1123–1130PubMedCrossRefGoogle Scholar
  6. Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D.T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M.D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T.R., Tonin, P. , Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B.A.J., Gayther, S.A., Birch, J.M., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y. , Borg, A., Hamann, U., Haites, N., Scott, R.J., Maugard, C.M., and Vasen, H. 1998. Genetic heterogeneity and penetrance analysis of BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62: 676–689PubMedCrossRefGoogle Scholar
  7. Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quintanilla, M., and Cano, A. 1993. Correlation of E-cadherin expression with dif ferentiation grade and histological type in breast carcinoma. Am. J. Pathol. 142: 987–993PubMedGoogle Scholar
  8. Holland, R., Veling, S.H., Mravunac, M., and Hendriks, J.H. 1985. Pathologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56: 979–990CrossRefGoogle Scholar
  9. Holland, R., Peterse, J.L., Millis, R.R., Eusebi, V. , Faverly, D., van de Vijver, M.J., and Zafrani, B. 1994. Ductal carcinoma-in-situ: a proposal for a new classification. Semin. Diagn. Path. 11: 167–180Google Scholar
  10. Honrado, E., Benítez, J., and Palacios, J. 2006. Histopathology of BRCA1- and BRCA2-associ ated breast cancer. Crit. Rev. Oncol. Hematol. 59: 27–39PubMedCrossRefGoogle Scholar
  11. Hoogerbrugge, N., Bult, P., de Widt-Levert, L.M., Beex, L.V., Kiemeney, L.A., Ligtenberg, M.J., Massuger, L.F., Boetes, C., Manders, P., and Brunner, H.G. 2003. High prevalence of pre-malignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J. Clin. Oncol. 21: 41–45PubMedCrossRefGoogle Scholar
  12. Hoogerbrugge, N., Bult, P., Bonenkamp, J.J., Ligtenberg, M.J., Kiemeney, L.A., de Hullu, J.A., Boetes, C., Niermeijer, M.F., and Brunner, H.G. 2006. Numerous high-risk epithelial lesions in familial breast cancer. Eur. J. Cancer 42: 2492–2498PubMedCrossRefGoogle Scholar
  13. Hutter, R.V. 1984. The management of patients with lobular carcinoma in situ of the breast. Cancer 53: 798–802PubMedCrossRefGoogle Scholar
  14. Hwang, E.S., McLennan, J.L., Moore, D.H., Crawford, B.B., Esserman, L.J., and Ziegler, J.L. 2007. Ductal carcinoma in situ in BRCA muta tion carriers. J. Clin. Oncol. 25: 642–647PubMedCrossRefGoogle Scholar
  15. Kauff, N.D., Brogi, E., Scheuer, L., Pathak, D.R., Borgen, P.I., Hudis, C.A., Offit, K., and Robson, M.E. 2003. Epithelial lesions in prophylac tic mastectomy specimens from women with BRCA mutations. Cancer 97: 1601–1608PubMedCrossRefGoogle Scholar
  16. Kriege, M., Brekelmans, C.T.M., Boetes, C., Besnard, P.E., Zonderland, H.M., Obdeijn, I.M., Manoliu, R.A., Kok, T., Peterse, H., Tilanus-Linthorst, M.M.A., Muller, S.H., Meijer, S., Oosterwijk, J.C., Beex, L.V.A.M., Tollenaar, R.A.E.M., de Koning, H.J., Rutgers, E.J.T., and Klijn, J.G., for the Magnetic Resonance Imaging Screening Study Group. 2004. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposi tion. N. Engl. J. Med. 351: 427–437PubMedCrossRefGoogle Scholar
  17. Lakhani, S.R., Audretsch, W., Cleton-Jensen, A.M., Cutuli, B., Ellis, I., Eusebi, V. , Greco, M., Houslton, R.S., Kuhl, C.K., Kurtz, J., Palacios, J., Peterse, H., Rochard, F., and Rutgers, E., on behalf of EUSOMA. 2006. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur. J. Cancer 42: 2205–2211PubMedCrossRefGoogle Scholar
  18. Lostumbo, L., Carbine, N., Wallace, J., and Ezzo, J. 2004. Prophylactic mastectomy for the preven tion of breast cancer. Cochrane. Database. Syst. Rev. Oct 18: CD002748Google Scholar
  19. Meijers-Heijboer, H., van Geel, B., van Putten, W.L.J., Henzen-Logmans, S.C., Seynaeve, C., Menke-Pluymers, M.B.E., Bartels, C.C.M., Verhoog, L.C., van den Ouweland, A.M.W., Niermeijer, M.F., Brekelmans, C.T.M., and Klijn, J.G.M. 2001. Breast cancer after prophy lactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 345: 159–164PubMedCrossRefGoogle Scholar
  20. Metcalfe, K., Lynch, H.T., Chadirian, P., Tung, N., Olivotto, V. , Warner, E., Olopade, O.I., Eisen, A., Weber, B., McLennan, J., Sun, P., Foulkes, W.D., and Narod, S.A. 2004. Contralateral breast can cer in BRCA1 and BRCA2 mutation carriers. J. Clin. Oncol. 22: 2328–2335PubMedCrossRefGoogle Scholar
  21. Page, D.L., and Rogers, L.W. 1992. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum. Pathol. 23: 1095–1097PubMedCrossRefGoogle Scholar
  22. Pinder, S.E., and Ellis, I.O. 2003. The diagnosis and management of pre-invasive breast disease: duc tal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) — current definitions and clas sification. Breast Cancer Res. 5: 254–257PubMedCrossRefGoogle Scholar
  23. Rebbeck, T.R., Friebel, T., Lynch, H.T., Neuhausen, S.L., van 't Veer, L., Garber, J.E., Evans, G.R., Narod, S.A., Isaacs, C., Matloff, E., Daly, M.B., Olopade, O.I., and Weber, B.L. 2004. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J. Clin. Oncol. 22: 1055–1062PubMedCrossRefGoogle Scholar
  24. van Roosmalen, M.S., Stalmeier, P.F., Verhoef, L.C., Hoogerbrugge, N., and van Daal, W.A.J. 2002. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. J. Clin. Oncol. 20: 2092–3000PubMedCrossRefGoogle Scholar
  25. Rosen, P.P., Braun, D.W., and Kinne, D.W. 1980. The clinical significance of pre-invasive breast carcinoma. Cancer 46: 35–51Google Scholar
  26. Simpson, P.T., Gale, T., Fulford, L.G., Reis, J.S., and Lakhani, S.R. 2003. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res. 5: 258–262PubMedCrossRefGoogle Scholar
  27. Singletary, S.E. 1994. Lobular carcinoma in situ of the breast: 31 year experience at the University of Texas, M.D. Anderson Cancer Center. Breast Dis. 7: 157–163Google Scholar
  28. Sun, C.C., Lenoir, G., Lynch, H., and Narod, S.A. 1996. In-situ breast cancer and BRCA1. Lancet 348: 408PubMedCrossRefGoogle Scholar
  29. Tavassoli, F.A., and Devilee, P. , editors. 2003. World Health Organisation Classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC PressGoogle Scholar
  30. Verhoog, L.C., Brekelmans, C.T., Seynaeve, C., Meijers-Heijboer, E.J., and Klijn, J.G. 2000. Contralateral breast cancer risk is influenced by the age at onset in BRCA1 associated breast cancer. Br. J. Cancer 83: 384–386PubMedCrossRefGoogle Scholar
  31. Welch, H.G., and Black, W.C. 1997. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Intern. Med. 127: 1023–1028PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2008

Authors and Affiliations

  • Peter Bult
    • 1
  • Nicoline Hoogerbrugge
    • 1
  1. 1.849 Human GeneticsHB NijmegenThe Netherlands

Personalised recommendations